• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

对公告机构的调查显示,高风险医疗器械的有条件认证使用非常有限。

Survey of Notified Bodies reveals very limited use of conditional certification for high-risk medical devices.

作者信息

Dobrzynska A, Rejon-Parrilla J C, Epstein D, Aranda-López J, Fraser A G, Blasco-Amaro J A

机构信息

Health Technology Assessment Area (AETSA), Andalusian Public Foundation Progress and Health (FPS), Seville, Spain.

Department of Applied Economics, University of Granada, Granada, Spain.

出版信息

Front Med Technol. 2025 Feb 3;7:1504294. doi: 10.3389/fmedt.2025.1504294. eCollection 2025.

DOI:10.3389/fmedt.2025.1504294
PMID:39963190
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11830701/
Abstract

The aim was to identify the experiences of Notified Bodies (NBs) in Europe in applying restrictions or limitations to certificates for high-risk medical devices. A survey examining NB practices regarding restrictions or limitations applied to Class III and IIb implantable medical devices was conducted as part of the CORE-MD Horizon 2020 project. Thirteen NBs responded; three had issued certificates of conformity with restrictions or limitations. NBs reported challenges in collecting and providing data on conditional certification, which would likely increase their workload. Enhancing clarity of regulatory standards, improving data transparency, fostering stakeholders' collaboration, and providing targeted training are essential to ensure uniform and homogeneous application of conditional certifications across the EU.

摘要

目的是确定欧洲公告机构(NBs)在对高风险医疗器械证书施加限制方面的经验。作为“核心医疗器械(CORE-MD)2020地平线”项目的一部分,开展了一项调查,考察NBs对III类和IIb类植入式医疗器械施加限制的做法。13个NBs做出了回应;其中3个已颁发了带有限制条件的合格证书。NBs报告称在收集和提供有关有条件认证的数据方面存在挑战,这可能会增加其工作量。提高监管标准的清晰度、改善数据透明度、促进利益相关者的合作以及提供有针对性的培训,对于确保在欧盟范围内统一且一致地应用有条件认证至关重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b35b/11830701/0f9b6a89da1f/fmedt-07-1504294-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b35b/11830701/0f9b6a89da1f/fmedt-07-1504294-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b35b/11830701/0f9b6a89da1f/fmedt-07-1504294-g001.jpg

相似文献

1
Survey of Notified Bodies reveals very limited use of conditional certification for high-risk medical devices.对公告机构的调查显示,高风险医疗器械的有条件认证使用非常有限。
Front Med Technol. 2025 Feb 3;7:1504294. doi: 10.3389/fmedt.2025.1504294. eCollection 2025.
2
Regulatory perspectives on post-market evidence generation schemes for high-risk medical devices: a systematic review.高风险医疗器械上市后证据生成方案的监管视角:一项系统综述
Expert Rev Pharmacoecon Outcomes Res. 2024 Dec 1:1-15. doi: 10.1080/14737167.2024.2431234.
3
Priorities for medical device regulatory approval: a report from the European Society of Cardiology Cardiovascular Round Table.医疗器械监管批准的优先事项:欧洲心脏病学会心血管圆桌会议报告
Eur Heart J. 2025 Apr 22;46(16):1469-1479. doi: 10.1093/eurheartj/ehaf069.
4
Improved clinical investigation and evaluation of high-risk medical devices: the rationale and objectives of CORE-MD (Coordinating Research and Evidence for Medical Devices).改进高风险医疗器械的临床研究和评估:CORE-MD(医疗器械协调研究和证据)的原理和目标。
Eur Heart J Qual Care Clin Outcomes. 2022 May 5;8(3):249-258. doi: 10.1093/ehjqcco/qcab059.
5
Improved clinical investigation and evaluation of high-risk medical devices: the rationale and objectives of CORE-MD (Coordinating Research and Evidence for Medical Devices).高风险医疗器械临床研究与评估的改进:CORE-MD(医疗器械协调研究与证据)的基本原理与目标
EFORT Open Rev. 2021 Oct 19;6(10):839-849. doi: 10.1302/2058-5241.6.210081. eCollection 2021 Oct.
6
Artificial intelligence in medical device software and high-risk medical devices - a review of definitions, expert recommendations and regulatory initiatives.人工智能在医疗器械软件和高风险医疗器械中的应用——定义、专家建议和监管举措的综述。
Expert Rev Med Devices. 2023 Jun;20(6):467-491. doi: 10.1080/17434440.2023.2184685. Epub 2023 May 8.
7
Navigating Medical Device Certification: A Qualitative Exploration of Barriers and Enablers Amongst Innovators, Notified Bodies and Other Stakeholders.医疗器械认证的探索:创新者、公告机构和其他利益相关者之间的障碍和促进因素的定性研究。
Ther Innov Regul Sci. 2023 Mar;57(2):238-250. doi: 10.1007/s43441-022-00463-4. Epub 2022 Oct 4.
8
Quality and transparency of evidence for implantable cardiovascular medical devices assessed by the CORE-MD consortium.COREMDS 联盟评估的心血管植入医疗器械的证据质量和透明度。
Eur Heart J. 2024 Jan 14;45(3):161-177. doi: 10.1093/eurheartj/ehad567.
9
[Requirements for CE-marking of apps and wearables].[应用程序和可穿戴设备的CE认证要求]
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2018 Mar;61(3):314-320. doi: 10.1007/s00103-018-2694-2.
10
Approval and Certification of Ophthalmic AI Devices in the European Union.欧盟眼科人工智能设备的批准与认证
Ophthalmol Ther. 2023 Apr;12(2):633-638. doi: 10.1007/s40123-023-00652-w. Epub 2023 Jan 18.

本文引用的文献

1
Regulatory perspectives on post-market evidence generation schemes for high-risk medical devices: a systematic review.高风险医疗器械上市后证据生成方案的监管视角:一项系统综述
Expert Rev Pharmacoecon Outcomes Res. 2024 Dec 1:1-15. doi: 10.1080/14737167.2024.2431234.
2
Orphan and paediatric medical devices in Europe: recommendations to support their availability for on-label and off-label clinical indications.欧洲的孤儿药和儿科医疗器械:支持其在标签内和标签外临床适应证使用的建议。
Expert Rev Med Devices. 2024 Oct;21(10):893-901. doi: 10.1080/17434440.2024.2404257. Epub 2024 Sep 20.
3
Quality and transparency of evidence for implantable cardiovascular medical devices assessed by the CORE-MD consortium.
COREMDS 联盟评估的心血管植入医疗器械的证据质量和透明度。
Eur Heart J. 2024 Jan 14;45(3):161-177. doi: 10.1093/eurheartj/ehad567.
4
Preparing healthcare, academic institutions, and notified bodies for their involvement in the innovation of medical devices under the new European regulation.为新的欧洲法规下医疗器械创新所涉及的医疗保健、学术机构和通知机构做好准备。
Expert Rev Med Devices. 2022 Aug;19(8):613-621. doi: 10.1080/17434440.2022.2118046. Epub 2022 Sep 4.
5
The European Medical Device Regulation-What Biomedical Engineers Need to Know.《欧盟医疗器械法规——生物医学工程师须知》。
IEEE J Transl Eng Health Med. 2022 Jul 28;10:4800105. doi: 10.1109/JTEHM.2022.3194415. eCollection 2022.
6
Improved clinical investigation and evaluation of high-risk medical devices: the rationale and objectives of CORE-MD (Coordinating Research and Evidence for Medical Devices).改进高风险医疗器械的临床研究和评估:CORE-MD(医疗器械协调研究和证据)的原理和目标。
Eur Heart J Qual Care Clin Outcomes. 2022 May 5;8(3):249-258. doi: 10.1093/ehjqcco/qcab059.
7
Recent Advances in Drug Development and Regulatory Science in China.中国药物研发与监管科学的最新进展
Ther Innov Regul Sci. 2018 Nov;52(6):739-750. doi: 10.1177/2168479018764661. Epub 2018 Apr 3.
8
Report of a European Society of Cardiology-European Association of Percutaneous Cardiovascular Interventions task force on the evaluation of coronary stents in Europe: executive summary.欧洲心脏病学会-欧洲经皮心血管介入学会评估欧洲冠状动脉支架工作组报告:执行摘要。
Eur Heart J. 2015 Oct 7;36(38):2608-20. doi: 10.1093/eurheartj/ehv203. Epub 2015 Jun 12.